Insights & news

French Competition Authority Publishes Report on Distribution of Medicines and on Laboratory Testing

  • 08/04/2019
  • Articles

On 4 April 2019, the French competition authority published a voluminous sector report on the distribution of medicines and on laboratory testing (the “Report” - see attached). The Report is the result of an inquiry which started in November 2017 (see, Van Bael & Bellis Life Sciences Newsflash of 21 November 2017) and which was also the subject of public consultations in October 2018 (see, Van Bael & Bellis Life Sciences Newsflash of 18 0ctober 2018).
 
The Report contains a series of regulatory recommendations which the competition authority says will help pharmacists to become more competitive while continuing to observe their public service obligations in the interest of public health. The Report thus advocates the following measures: 

  • Loosening the rules governing online sales by (i) allowing pharmacies more leeway in having storage facilities further removed from the pharmacy; (ii) allowing pharmacists to pool their online activities by relying on a common website; and (iii) changing the financial thresholds for recruiting assistant pharmacists by no longer considering for that purpose sales of non-medicine products;
  • Taking additional measures to stimulate take-off of relatively recent public service tasks such as involvement in vaccination campaigns; fostering patient treatment adherence; and the development of telemedicine services;
  • Considering new public service tasks such as tracking non-communicable diseases or administering specific medicines under narrow conditions;
  • Relaxing the advertising rules for cosmetics and other non-medicine products as well for the pharmacy business as such;
  • Increasing the pharmacy’s access to capital;
  • Allowing specific non-medicine products (such as in vitro diagnostic medical devices) to be sold outside pharmacies – it is unclear how this proposed measure will help pharmacies.

The Report also invites the government to reconsider the income of the wholesalers-distributors which live on small margins (often smaller than those of pharmacies that buy medicines directly from suppliers) while having to cope with public service obligations.

Attachments:

Key contacts

Related practice areas

Related insights

Sign up for updates
    • 04/06/2020
    • Articles

    Europe - Four-Country Inclusive Vaccine Alliance In Quest for Covid-19 Vaccine

    In a letter to Parliament and a press release (see, attachments), the Dutch Minister for Public Health, Wellbeing and Sports, Hugo de Jonge, revealed on 3 June 2020 an initiative of Italy, France, Germany and The Netherlands to work together to secure a Covid-19 vaccine for “the European Union and other countries”.   According to the Minister, the “Inclusive Vaccine Alliance” (IVA) is in talks with several pharmaceutical companies regarding promising ventures and in the process hopes to establish a European manufacturing base for the vaccine. The IVA’s ultimate goal is to create a medicine that is “accessible, available and affordable”.   Other countries will be given the opportunity to join the IVA which is also in contact with the European Commission.

    Read more
    • 03/06/2020
    • Articles

    European Commission Publishes Roadmap Towards Pharmaceutical Strategy for Europe

    The European Commission (the Commission) published on 2 June 2020 its roadmap towards a Pharmaceutical Strategy for Europe (PSE) which it plans to publish in the fourth quarter of 2020 (see, attachment). The roadmap defines the steps which the Commission will take prior to adopting the PSE and the data which it will assemble to inform its PSE. While the Commission will consult a range of stakeholders, it has already announced a public consultation which will run until 7 July 2020.

    Read more
    • 02/06/2020
    • Articles

    Italian Competition Authority Approves Scheme for Distribution of Surgical Masks

    On 1 June 2020, the Italian competition authority (“L’Autorità Garante della Concorrenza e del Mercato”) authorised a scheme that would allow disposable surgical masks to be distributed and sold in pharmacies and health product retail outlets (see, attached press release). It did so at the request of the two principal Italian associations of pharmaceutical wholesalers. Under the scheme, the wholesalers and associations of pharmacists and health product retailers acquire the masks in a joint procurement procedure. The masks are then allocated among the wholesalers at a uniform price per unit that was agreed upon with the suppliers. The scheme will last until 30 June 2020. The competition authority approved the scheme because it solves an urgent and wide-ranging health problem and is limited in time. It thus applied for the first time the principles of its guidance of 22 April 2020 regarding cooperation agreements designed to ensure the distribution of scarce essential goods and services, including health products and food. The competition authority’s approach is in line with the views expressed by the European Commission and competition authorities around Europe to address the problems resulting from the Covid-19 pandemic (see e.g., Van Bael & Bellis Life Sciences News Alert of 9 April 2020 and of 26 May 2020). Not coincidentally, the competition authority indicates that it obtained counsel from the European Commission.

    Read more

Subscribe to our updates

Please select the practice areas you are interested in: *